ITRM910085A1 - Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. - Google Patents

Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.

Info

Publication number
ITRM910085A1
ITRM910085A1 IT000085A ITRM910085A ITRM910085A1 IT RM910085 A1 ITRM910085 A1 IT RM910085A1 IT 000085 A IT000085 A IT 000085A IT RM910085 A ITRM910085 A IT RM910085A IT RM910085 A1 ITRM910085 A1 IT RM910085A1
Authority
IT
Italy
Prior art keywords
ovarian
cancer therapy
pharmaceutical product
active principle
hemopoietic system
Prior art date
Application number
IT000085A
Other languages
English (en)
Inventor
Pier Luigi Benedetti-Panici
Arnaldo Capelli
Giancarlo Folchitto
Salvatore Mancuso
Mauro Piantelli
Franco Oreste Ranelletti
Giovanni Scambia
Original Assignee
Dalla Costa Giorgio
Giancarlo Folchitto
Salvatore Mancuso
Romeo Francesco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalla Costa Giorgio, Giancarlo Folchitto, Salvatore Mancuso, Romeo Francesco filed Critical Dalla Costa Giorgio
Priority to ITRM910085A priority Critical patent/IT1244647B/it
Publication of ITRM910085A0 publication Critical patent/ITRM910085A0/it
Priority to JP4505072A priority patent/JPH07502009A/ja
Priority to AU12691/92A priority patent/AU1269192A/en
Priority to EP92905230A priority patent/EP0570475A1/en
Priority to PCT/IT1992/000007 priority patent/WO1992013851A1/en
Publication of ITRM910085A1 publication Critical patent/ITRM910085A1/it
Application granted granted Critical
Publication of IT1244647B publication Critical patent/IT1244647B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
ITRM910085A 1991-02-05 1991-02-05 Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo. IT1244647B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
ITRM910085A IT1244647B (it) 1991-02-05 1991-02-05 Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.
JP4505072A JPH07502009A (ja) 1991-02-05 1992-01-31 クエルセチン化合物を活性物質として含有する腫瘍、特に卵巣及び造血系の腫瘍の治療用薬剤
AU12691/92A AU1269192A (en) 1991-02-05 1992-01-31 Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances
EP92905230A EP0570475A1 (en) 1991-02-05 1992-01-31 Pharmaceutical preparation for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances
PCT/IT1992/000007 WO1992013851A1 (en) 1991-02-05 1992-01-31 Pharmaceutical product for the therapy of tumors, particularly ovarian and haemopoietic system tumors, containing quercetin compounds as active substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM910085A IT1244647B (it) 1991-02-05 1991-02-05 Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.

Publications (3)

Publication Number Publication Date
ITRM910085A0 ITRM910085A0 (it) 1991-02-05
ITRM910085A1 true ITRM910085A1 (it) 1992-08-05
IT1244647B IT1244647B (it) 1994-08-08

Family

ID=11399834

Family Applications (1)

Application Number Title Priority Date Filing Date
ITRM910085A IT1244647B (it) 1991-02-05 1991-02-05 Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.

Country Status (5)

Country Link
EP (1) EP0570475A1 (it)
JP (1) JPH07502009A (it)
AU (1) AU1269192A (it)
IT (1) IT1244647B (it)
WO (1) WO1992013851A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20010600A1 (it) * 2001-10-04 2003-04-04 Brane Tech S R L Composti flavonoidici capaci di modificare lo stato fisico e/o dinamico di membrane biologiche e di stimolare la sintesi endogena di protein
US20120225033A1 (en) * 2010-11-24 2012-09-06 Durect Corporation Biodegradable Drug Delivery Composition
TWI660680B (zh) 2012-11-26 2019-06-01 美商通路實業集團國際公司 抗氧化膳食增補劑及其相關方法
CN111068095B (zh) * 2020-02-07 2021-07-13 中国科学院上海硅酸盐研究所 高效诱导烧伤创面毛囊再生的生物活性离子改性槲皮素螯合剂组合物及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892845A (en) * 1957-11-26 1959-06-30 Jurd Leonard Selective etherification of the 7-hydroxyl group in polyhydroxy flavonoids
FR3541M (fr) * 1964-05-12 1965-09-13 Laroche Navarron Lab Médicament a propriétés natriurétiques a base d'une nouvelle flavone.

Also Published As

Publication number Publication date
ITRM910085A0 (it) 1991-02-05
WO1992013851A1 (en) 1992-08-20
EP0570475A1 (en) 1993-11-24
AU1269192A (en) 1992-09-07
IT1244647B (it) 1994-08-08
JPH07502009A (ja) 1995-03-02

Similar Documents

Publication Publication Date Title
BG98902A (bg) Имидазолови производни и тяхната употреба като инхибитори на цитокин
ATA244992A (de) Stabilisiertes pharmazeutisches mittel, enthaltend einen hmg-coa-reduktase-inhibitor wirkstoff
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
ATE67930T1 (de) Wirkstofftraeger und diesen enthaltende arzneimittel.
MY111791A (en) Aqueous gel retinoid dosage form.
GR3023638T3 (en) Isoxazole-4-carboxamides and hydroxyalkylidene-cyanoacetamides, drugs containing these compounds and use of such drugs
NO944700D0 (no) Nye tienotiazinderivater, fremgangsmåte for fremstilling derav samt farmasöytiske preparater inneholdende forbindelsene
FI822943A7 (fi) Tromboksaanisyntetaasi-estoaineita, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisiayhdistelmiä.
DE3669104D1 (de) Pharmazeutische praeparate, die ascorbinsaeurederivate enthalten.
NO934706D0 (no) Substituerte 4-fenyl-pyridoner og 4-fenyl-2-alkoksypyridiner
IT8584151A0 (it) Procedimento per la sanitizzazione di contenitori e materiali di confezionamento, particolarmente per uso farmaceutico e cosmetico, ed impianto per effettuare il procedimento.
NL191307C (nl) Analgetisch werkzame piperazinederivaten en farmaceutische preparaten, die deze derivaten bevatten.
DE69422712D1 (de) Tris-platin-komplexe
TW290455B (it)
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
ITRM910085A1 (it) Prodotto farmaceutico per la terapia dei tumori, in particolare di quelli ovarici e del sistema emopoietico, contenente quercitina come principio attivo.
DE3874390D1 (de) Carboxystyrol-derivate und arzneimittel, die sie als wirkstoff enthalten.
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
DE69104608D1 (de) Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis.
IT8221331A0 (it) Eterociclilfenilformamidine, processi per la loro preparazione e loro uso farmaceutico.
IT8320588A0 (it) Derivati del furano e relativi sali di addizione, procedimenti per laloro preparazione, composti farmaceutici e loro applicazioni terapeutiche.
IT8220356A0 (it) Guanidino eterociclifenilamidine, processi per la loro preparazione e loro impiego farmaceutico.
ZA928127B (en) Use of substituted pyrrolidines, some of which are known, as medicaments, new active substances and processes for their preparation.
ATA190595A (de) Stabilisiertes pharmazeutisches mittel, enthaltend fluvastatin-natrium als wirkstoff
FI832921A7 (fi) Imidatsolijohdannaiset ja niiden suoloja, synteesejä sekä farmaseuttisia valmisteita.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960215